• Home
  • Search Results

Search Results

436 studies match your search
Coming Soon

Phase 3 Study of RMC-6236 in Previously Treated NSCLC Patients with RAS Mutations

The purpose of this study is to test an experimental drug called RMC-6236. RMC-6236 is an experimental drug, which means that it is not approved by the United States (US) Food and Drug Administration (FDA) or any other health authorities. RMC-6236 is currently being investigated in other ongoing studies in non-small cell lung cancer (NSCLC). If you consent and meet the study requirements, you will be randomly assigned to receive either RMC-6236 or docetaxel.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung)
Coming Soon

Zilovertamab Vedotin+R-CHP vs Polatuzumab Vedotin+R-CHP for 1L DLBCL, GCB

The purpose of this study is to evaluate the efficacy and safety of zilovertamab vedotin plus R-CHP versus polatuzumab vedotin plus R-CHP for the treatment of the GCB subtype of DLBCL.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

Study of AUTX-007 for Leukemia

If you have Leukemia and are looking for an alternative treatment, you may be eligible to participate in a research study testing a new drug called AUTX-007.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Coming Soon

Tirzepatide in women with obesity and endometrial neoplasia or endometrial cancer

In this study, we want to look at how the drug tirzepatide works in patients with endometrial cancer compared to the standard of care treatment. We will be looking at its effect on the progression of the tumor.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
Coming Soon

PROMOTE: ImPact of the MicRobiome and ImmunOtherapy on the TreatMent and ProgressiOn of EndomeTrial CancEr

The purpose of this study is to learn how microbes in the uterus and gut (bacteria, viruses, fungi) and your own innate immune system (the first line of defense of the body) impacts how well certain treatments work for endometrial cancer. This is a hybrid decentralized study where some if not all assessments may be performed close to your home.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))

Prostate Cancer surveillance and Green Tea

Researchers are trying to find out if they can slow the growth of prostate cancer by adding green tea to patients treatment. Researchers are also trying to find out if this could be better or worse than usual care patients get.

Age & Gender
  • 21 years ~ 99 years
  • Male
Study Interest
  • Cancer (Prostate)
Coming Soon

Study on a New Treatment for Recurrent Respiratory Papillomatosis (RRP)

We are doing a study to see if a new treatment, called INO-3107, can help people with recurrent respiratory papillomatosis (RRP). We want to find out if this treatment works well and if it helps patients need fewer surgeries in the future.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
  • Lungs and Breathing
Open

Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN

Do you have incurable, metastatic head and neck squamous cell carcinoma ? If so, you may be able to take part in a study to see if a new drug called Cisplatin is effective.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Open

Young Adult Alcohol Use and Social Media Study

Are you a young adult who drinks and uses social media? We are holding in-person workshops in downtown Chapel Hill to gather feedback from young adults who drink and use social media. Compensation provided.

Age & Gender
  • 18 years ~ 25 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Cancer (Breast, Colorectal, Head and Neck, and 2 more)
  • Substance Use (tobacco, alcohol, opioids, etc)
Visit Location
Coming Soon

Leukemia Treatment Study

In this study, we want to see if a new drug called LBS-007 can help treat or cure leukemia. We want to find out if it is safe and if it works well for people with this disease.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research